Fixed Tilt (65%)
DeviceThis is the standard group, so device programming for shock energy is the default setting
NCT Number: NCT03632057
This is a prospective, 1:1 randomized, interventional, multicenter and international trial. Approximately 790 subjects are expected to be enrolled to 40 sites in the south of Europe and Middle East.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hospital Virgen de la Victoria, Málaga, Andalusia, Spain
The objective of this study is to evaluate and compare the efficacy of the first appropriate shock of an ICD in a ventricular tachyarrhythmia, when the waveform of the shock is programmed with the standard waveform, Fixed Tilt with a value of 65% (Control Group), versus the exclusive waveform programmable in SJM ICDs, Fixed Pulse Width (Study Group), in a standard population of subjects with ICD indication.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is the standard group, so device programming for shock energy is the default setting
The device has to be programmed with fixed pulse width for each phase of the biphasic waveform
Time frame: 5 years
Rate of rhythm conversion from Ventricular Tachyarrhythmia to sinus rhythm by the first appropriate shock programmed to 25 Joules (or equivalent voltage) programming the shock waveform in Fixed Pulse Width (Study Group) versus the Fixed Tilt with value 65% (Control Group).
Abbott Medical Devices
Industry
Shock Efficacy, a Randomized Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population
Acronym: EFICAZ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06378996
Cardiovascular Diseases, Heart Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT03495297
Ventricular Arrythmia
Orlando, Florida, United States
View Trial DetailsNCT06203262
Arrhythmias, Cardiac, Cardiac Complexes, Premature
Prague, Czechia
View Trial DetailsNCT05938283
Aortic Stenosis, Subvalvular, Aortic Valve Disease
London, United Kingdom
View Trial Details